A New Jersey jury on Friday awarded $9 million each to two people who took the anti-acne drug Accutane, made by Hoffmann-La Roche (RHHBY.PK), and developed bowel disease. Accutane causes inflammatory bowel disease in some individuals.
This was the eighth Accutane case to go to trial in the U.S. To date, plaintiffs have won over $78 million in verdicts against Roche.
The trial lasted almost two months. The jury turned back the claims of two other clients as it found that although Roche failed to warn their prescribing physicians of the dangers of Accutane, they would have been prescribed and taken Accutane anyway.
Click here to receive FREE breaking news email alerts for Roche Holding AG and others in your portfolio
by RTT Staff Writer
For comments and feedback: firstname.lastname@example.org